ProShare Advisors
NUVB icon

ProShare Advisors’s Nuvation Bio NUVB Stock Holding History

ProShare Advisors’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$187K Sell
33,006
-1,943
-6% -$9.5K ﹤0.01% 1663
2026
Q1 		$150K Sell
34,949
-9,135
-21% -$50.9K ﹤0.01% 1648
2025
Q4 		$395K Buy
44,084
+1,409
+3% +$8.73K ﹤0.01% 1272
2025
Q3 		$158K Sell
42,675
-8,501
-17% -$23.2K ﹤0.01% 1754
2025
Q2 		$99.8K Buy
51,176
+11,928
+30% +$24.8K ﹤0.01% 1878
2025
Q1 		$69.1K Sell
39,248
-11,812
-23% -$26.9K ﹤0.01% 1906
2024
Q4 		$136K Buy
51,060
+16,801
+49% +$43.3K ﹤0.01% 2000
2024
Q3 		$78.5K Buy
34,259
+14,746
+76% +$45K ﹤0.01% 1919
2024
Q2 		$57K Sell
19,513
-6,660
-25% -$20.3K ﹤0.01% 1733
2024
Q1 		$95.3K Buy
26,173
+2,062
+9% +$3.96K ﹤0.01% 1831
2023
Q4 		$36.4K Buy
24,111
+5,186
+27% +$6.67K ﹤0.01% 1888
2023
Q3 		$25.4K Sell
18,925
-21
-0.1% -$35 ﹤0.01% 1770
2023
Q2 		$34.1K Buy
18,946
+5,246
+38% +$8.92K ﹤0.01% 1808
2023
Q1 		$22.7K Sell
13,700
-1,277
-9% -$2.59K ﹤0.01% 1725
2022
Q4 		$28.8K Buy
14,977
+2,147
+17% +$4.34K ﹤0.01% 1787
2022
Q3 		$30K Sell
12,830
-245
-2% -$700 ﹤0.01% 1700
2022
Q2 		$43K Sell
13,075
-16,732
-56% -$73K ﹤0.01% 1722
2022
Q1 		$157K Sell
29,807
-4,924
-14% -$27.7K ﹤0.01% 1945
2021
Q4 		$295K Buy
+34,731
New +$319K ﹤0.01% 1801

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

ProShare Advisors's NUVB Position: Q2 2026 in Review

ProShare Advisors reduced its Nuvation Bio (NUVB) stake by 5.6% in Q2 2026, selling an estimated $9.5K and leaving 33,006 shares worth $187K. The position accounts for ﹤0.01% of the portfolio, ranked #1663.

ProShare Advisors first reported a position in NUVB in Q4 2021 and has held it in 19 quarters since. The position peaked at $395K in Q4 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • ProShare Advisors held 33,006 shares of Nuvation Bio worth $187K as of Q2 2026.
  • ProShare Advisors sold 1,943 Nuvation Bio shares in Q2 2026, an estimated $9.5K.
  • Nuvation Bio made up ﹤0.01% of ProShare Advisors's portfolio in Q2 2026, its #1663 holding.
  • ProShare Advisors first reported a position in Nuvation Bio in Q4 2021 and has held it in 19 quarters since.
  • ProShare Advisors's Nuvation Bio position peaked at $395K in Q4 2025.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.